Replies to post #142384 on Anavex Life Sciences Corp (AVXL)

[XenaLives]

Bingo -

No debate on the failure to start the promised 3 trials but this recent news from Phizer on their AD trials stopping after 20+ years of work does present some context for the AVXL miss. A number of other BP's also stopped AD trials. They had trails running and STOPPED them, without any data driven explanation...like we just got additional clinical results???

We are all tremendously let down by the pull back of A2-73 planned starts however the impact is somewhat mitigated by the fact that all BP (except for BIIB) have pulled their AD plugs. WHY?

We may never know what has just happened but it MUST have been significant.

[Investor2014]

I predict that BIIB will either continue their trial and fail or pull the plug and save some face and a little money. I just cannot imagine any other options.

All the BP failures in AD of course is not equal Anavex will succeed. But, could it increase the chances of a deal?

[baltimorebullet]

But that's just another theory.
And a fine one it is.
There are many fine theories on this board.

I (and perhaps some of you) have ridden a few biotechs down deep into the canyon.
And all the way down hope springs eternal.
Humans love stories and Anavex is a story stock.
I try very hard to avoid story stocks but I'm human and here I am.

You ask what happened.
I'd love to know too.
I'd also like to know why instead of a PD trial starting in late 2017 suddenly we're fixing to file in Europe.
I believe that deserves a thorough explanation.